1. Basic Policy on Information Disclosure
Kaken Pharmaceutical Co., Ltd. (“Kaken”) will disclose corporate information to its
stakeholders in a fair, timely and appropriate manner as stated in “Kaken’s Activity
Principles and Guidelines” and “Kaken’s Code of Conduct”.
Kaken will ensure management transparency and increase corporate value through fair,
timely and appropriate disclosure of corporate information and communication with its
2. Information for Disclosure
Kaken will disclose corporate information in a fair, timely and appropriate manner in
accordance with the statutory disclosure system based on the relevant laws such as the
Companies Act and the Financial Instruments and Exchange Act and the Timely Disclosure
Rules set forth by the Tokyo Stock Exchange.
In addition, Kaken will actively disclose the information that may affect investment decisions
of its stakeholders, even if it is not subject to either statutory disclosure or timely disclosure
3. Methods of Disclosure
Kaken will disclose information through the TDnet (Timely Disclosure network), Press
Release, and our corporate website.
4. Quiet Period
In order to prevent leaks of financial information and to ensure fairness in its disclosure,
Kaken will define the period from the next day of the end of each quarter to the day of its
financial announcement of the quarter as the "Quiet Period".
During the Quiet Period, Kaken will refrain from making any comments and responding to
any questions related to financial information.
However, if an earnings forecast is expected to significantly change during the Quiet
Period, Kaken will disclose the information in a timely and appropriate manner. Kaken will
also respond to the questions regarding the information which has already been released
even in the Quiet Period.
5. Disclosure of Future Prospects
The information pertaining to the future prospects, such as earnings forecasts, is based on
the information available at the time of disclosure and includes uncertainties.
6. Kaken Disclosure Committee
Kaken has formed the “Disclosure Committee" chaired by person responsible for handling
of information and deliberates and decides on information disclosure.